Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Efects of Oxaloacetate and l‐Glutamate on Glyceraldehyde 3‐Phosphate

View through CrossRef
A new coupled reaction for the measurement of aspartate aminotransferase activity with oxaloacetate and l‐glutamate as substrates is described. This reaction measures the appearance of the product, 2‐oxoglutarate, with 2‐oxoglutarate dehydrogenase. It avoids the high concentrations of phosphate or arsenate which have been used to catalyze tautomerization in those assays which utilize the absorbance of the enol form of oxaloacetate to measure its concentration. These salts inhibit the cationic isozyme of aspartate aminotransferase. Values for Km(oxaloacetate) and Km(l‐glutamate) were 0.037 mM and 7.8 mM, respectively, for rat liver anionic isozyme and 0.006 mM and 8.6 mM, respectively, for the cationic isozyme.Glyceraldehyde 3‐phosphate inhibition of the anionic isozyme was partially competitivepartially noncompetitive with respect to oxaloacetate and partialy noncompetitive with respect to l‐glutamate, with β= 0.31. Inhibition by glyceraldehyde‐3‐P of the cationic isozyme was non‐competitive with respect to l‐glutamate. Ki values for glyceraldehyde‐3‐P for the anionic isozyme were 0.57 mM in the presence of l‐glutamate and 1.5 mM in the presence of oxaloacetate. The Ki value for the cationic isozyme in the presence of l‐glutamate was 0.11 mM. These values are in agreement with those that were reported previously for inhibition in the presence of l‐aspartate and 2‐oxoglutarate. The similarity between the types of inhibition in both directions of transamination indicates that both keto acid substrates bind to the isozymes at a single site and compete with glyceraldehyde‐3‐P for that site. The noncompetitive nature of inhibition in the presence of amino acid substrates suggests that at least one point of their attachment is outside of the site to which the keto acids and glyceraldehyde‐3‐P bind.
Title: Efects of Oxaloacetate and l‐Glutamate on Glyceraldehyde 3‐Phosphate
Description:
A new coupled reaction for the measurement of aspartate aminotransferase activity with oxaloacetate and l‐glutamate as substrates is described.
This reaction measures the appearance of the product, 2‐oxoglutarate, with 2‐oxoglutarate dehydrogenase.
It avoids the high concentrations of phosphate or arsenate which have been used to catalyze tautomerization in those assays which utilize the absorbance of the enol form of oxaloacetate to measure its concentration.
These salts inhibit the cationic isozyme of aspartate aminotransferase.
Values for Km(oxaloacetate) and Km(l‐glutamate) were 0.
037 mM and 7.
8 mM, respectively, for rat liver anionic isozyme and 0.
006 mM and 8.
6 mM, respectively, for the cationic isozyme.
Glyceraldehyde 3‐phosphate inhibition of the anionic isozyme was partially competitivepartially noncompetitive with respect to oxaloacetate and partialy noncompetitive with respect to l‐glutamate, with β= 0.
31.
Inhibition by glyceraldehyde‐3‐P of the cationic isozyme was non‐competitive with respect to l‐glutamate.
Ki values for glyceraldehyde‐3‐P for the anionic isozyme were 0.
57 mM in the presence of l‐glutamate and 1.
5 mM in the presence of oxaloacetate.
The Ki value for the cationic isozyme in the presence of l‐glutamate was 0.
11 mM.
These values are in agreement with those that were reported previously for inhibition in the presence of l‐aspartate and 2‐oxoglutarate.
The similarity between the types of inhibition in both directions of transamination indicates that both keto acid substrates bind to the isozymes at a single site and compete with glyceraldehyde‐3‐P for that site.
The noncompetitive nature of inhibition in the presence of amino acid substrates suggests that at least one point of their attachment is outside of the site to which the keto acids and glyceraldehyde‐3‐P bind.

Related Results

Properties of the Recombinant β Subunit of Glutamate Synthase
Properties of the Recombinant β Subunit of Glutamate Synthase
Glutamate synthase is a complex iron‐sulfur flavoprotein containing one molecule each of FAD and FMN and three distinct iron‐sulfur centers/αβ protomer. Production of the β subunit...
P0883HEALTHY FEMALES EXCRETE MORE PHOSPHATE THAN MALES IN RESPONSE TO AN ORAL CHALLENGE
P0883HEALTHY FEMALES EXCRETE MORE PHOSPHATE THAN MALES IN RESPONSE TO AN ORAL CHALLENGE
Abstract Background and Aims There are disparities in the diagnosis, treatment and prognosis for cardiovascular disease (CVD) be...
Novel phosphate-based cements for clinical applications
Novel phosphate-based cements for clinical applications
This Thesis aims at the development of two novel families of inorganic phosphate cements with suitable characteristics for clinical applications in hard tissue regeneration or repl...
Glutathione induces ArabidopsisPHT1;5gene via WRKY75 transcription factor to regulate phosphate homeostasis
Glutathione induces ArabidopsisPHT1;5gene via WRKY75 transcription factor to regulate phosphate homeostasis
AbstractPhosphorus is a macronutrient that regulates a wide range of physiological processes, including plant growth and development. The scarcity of bioavailable phosphate is ofte...
P0894OBESITY IMPAIRS THE ACUTE RESPONSE TO AN ORAL PHOSPHATE CHALLENGE
P0894OBESITY IMPAIRS THE ACUTE RESPONSE TO AN ORAL PHOSPHATE CHALLENGE
Abstract Background and Aims T Obesity is an increasing health problem world-wide. People who are overweight or obese are at gre...
Kinetics of the Inhibition of Aspartate Aminotransferase Isozymes by dl‐Glyceraldehyde 3‐Phosphate
Kinetics of the Inhibition of Aspartate Aminotransferase Isozymes by dl‐Glyceraldehyde 3‐Phosphate
The inhibitor dissociation constants and types of inhibition of the isozymes of aspartate aminotransferase from rat liver by the time‐dependent inhibitor dl‐glyceraldehyde 3‐phosph...
Abstract 5473: Identification of compensatory pathway for glutamate production upon glutaminase 1 inhibition
Abstract 5473: Identification of compensatory pathway for glutamate production upon glutaminase 1 inhibition
Abstract Rationale and objectives: A current clinical trial is testing a drug inhibitor for glutaminase 1 (GLS1), the enzyme responsible for glutamine's conversion i...

Back to Top